Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Simulations Plus Inc SLP

Healthcare Medical Devices
Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. The Company's segments include software and services. It offers 12 software products for pharmaceutical research and development... see more

Recent & Breaking News (NDAQ:SLP)

Simulations Plus Reports First Quarter Fiscal 2022 Financial Results

Business Wire January 6, 2022

Lixoft Adds New Bioequivalence Module in MonolixSuite® Version 2021R1

Business Wire January 5, 2022

Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference Call

Business Wire December 20, 2021

Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix(TM)

Business Wire December 2, 2021

Simulations Plus celebrates 25-year anniversary with $25,000 gift to nonprofit Dispensary of Hope

PR Newswire November 30, 2021

Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope

Business Wire November 30, 2021

Simulations Plus Names Sharlene Evans to Board of Directors

Business Wire November 19, 2021

Simulations Plus Presented Breakthrough Scientific Data at Top Liver Disease Conference

Business Wire November 18, 2021

Simulations Plus Releases RENAsym® Version 1A Software for Kidney Injury

Business Wire November 16, 2021

Simulations Plus Releases GastroPlus® Version 9.8.2

Business Wire October 28, 2021

Simulations Plus and the University of Connecticut Awarded New FDA Contract to Accelerate the Development of Long-Acting Injectable Products

Business Wire October 26, 2021

Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results

Business Wire October 25, 2021

Simulations Plus Announces the University+ Program

Business Wire October 21, 2021

Simulations Plus Announces Cash Dividend

Business Wire October 13, 2021

Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call

Business Wire October 11, 2021

Simulations Plus Receives New Grant Award From the FDA

Business Wire September 23, 2021

Simulations Plus Releases ADMET Predictor® (X.3)

Business Wire September 15, 2021

Simulations Plus to Participate in BofA Securities and Oppenheimer Investor Conferences

Business Wire September 8, 2021

Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company

Business Wire August 19, 2021

NMPA's Center for Drug Evaluation Adds Licenses of GastroPlus®

Business Wire August 4, 2021